Apistan, 800 mg/8 g (10,3% w/w) taru ravimriba kodumesilastele
Apistan, 800 mg/8 g (10,3% w/w) taru ravimriba kodumesilastele
Authorised
- Tau-fluvalinate
Product identification
Medicine name:
Apistan, 800 mg/8 g (10,3% w/w) taru ravimriba kodumesilastele
Active substance:
- Tau-fluvalinate
Target species:
-
Honey bee
Route of administration:
-
In-hive use
Product details
Active substance and strength:
-
Tau-fluvalinate800.00/milligram(s)1.00Strip
Pharmaceutical form:
-
Bee-hive strip
Withdrawal period by route of administration:
-
In-hive use
- Honey bee
-
Honey0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP53AC10
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Estonia
Package description:
- Available only in Estonian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Vita (Europe) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Pharmapac Limited
Responsible authority:
- State Agency Of Medicines
Authorisation number:
- 1421
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 2/12/2021
How useful was this page?:
